Launched in 2017, in partnership with the National Comprehensive Cancer Network® (NCCN®), JNCCN 360 is a comprehensive, tumor-specific online news resource geared for a broad audience of oncology professionals.

With an assortment of tumor-specific microsites covering disease states from breast cancer to multiple myeloma, each tumor-specific microsite contains the following features:

  • JNCCN Spotlights, original feature articles on specific oncology drugs with clinical pearls from colleagues on how best to use them effectively and safely in practice
  • Latest oncology news from both major and minor medical meetings and the U.S. Food and Drug Administration
  • Key clinical trial findings and more from the medical literature
  • Video interviews with leading experts in oncology, sharing recent study findings, clinical insights, and challenging issues
  • Site Editors who are top thought leaders in oncology and NCCN Panel Members overseeing content curation
  • Ongoing CE activities, available clinical trials, and patient resources
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.